cooper develop said revis result for year end octob loss mln dlrs dlrs per share down from previous report loss mln dlrs cts per share restat was made becaus chang method account for combin sever compani control concern result mln dlr charg cooper develop said last august cooper develop combin it cooper biomed inc unit and it cooper laboratori subsidiari with technicon instrument corp compani acquir from revlon inc cooper spokesman said spokesman said transact was account for acquisit but secur and exchang commiss took issu with account method and said should account for reorgan entiti under common control this treatment requir cost associ with transact expand rather capit intang asset compani said also said sinc charg requir expens previous accru liabil compani will experi result materi chang it cash flow reuter 